SQZ BIOTECHNOLOGIES COMPANY Increase (Decrease) in Accounts Payable
SQZ BIOTECHNOLOGIES COMPANY reported Increase (Decrease) in Accounts Payable of -$598.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $350.00K, a 78.84% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$922.00K, a 304.43% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for the quarter ending 2023-03-31 was -$26.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$798.00K, a 150.47% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for fiscal 2022 was -$1.42M, a 232.40% decline from fiscal 2021.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for fiscal 2021 was $1.07M, a 974.00% increase from fiscal 2020.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for fiscal 2020 was $100.00K, a 94.15% decline from fiscal 2019.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts payable for fiscal 2019 was $1.71M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$572.00K derived: sum of 2 quarters · filed 2023-11-08 | -$598.00K 10-Q · filed 2023-11-08 | -$1.40M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -$922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$948.00K 10-Q · filed 2023-08-10 | -$1.75M derived: sum of 3 quarters · filed 2023-08-10 | -$92.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | -$26.00K 10-Q · filed 2023-05-10 | -$824.00K derived: sum of 2 quarters · filed 2023-05-10 | $830.00K derived: sum of 3 quarters · filed 2023-11-08 | $1.28M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | -$798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $856.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.31M derived: sum of 3 quarters · filed 2023-11-08 | -$1.42M 10-K · filed 2023-03-22 |
| 2022-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.10M derived: sum of 2 quarters · filed 2023-11-08 | -$624.00K 10-Q · filed 2023-11-08 | $957.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.28M 10-Q · filed 2023-08-10 | -$697.00K derived: sum of 3 quarters · filed 2023-08-10 | -$411.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$2.73M 10-Q · filed 2023-05-10 | -$1.15M derived: sum of 2 quarters · filed 2023-05-10 | -$862.00K derived: sum of 3 quarters · filed 2023-05-10 | -$2.23M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.87M derived: sum of 2 quarters · filed 2023-03-22 | $502.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.07M 10-K · filed 2023-03-22 |
| 2021-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.08M derived: sum of 2 quarters · filed 2022-11-09 | -$507.00K 10-Q · filed 2022-11-09 | $439.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$793.00K 10-Q · filed 2022-08-04 | $153.00K derived: sum of 3 quarters · filed 2022-08-04 | -$668.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $572.00K 10-Q · filed 2022-05-10 | $1.52M derived: sum of 2 quarters · filed 2022-05-10 | $697.00K derived: sum of 3 quarters · filed 2022-05-10 | $524.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $125.00K derived: sum of 2 quarters · filed 2022-03-16 | -$48.00K derived: sum of 3 quarters · filed 2022-03-16 | $100.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | -$821.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$994.00K derived: sum of 2 quarters · filed 2021-11-10 | -$846.00K 10-Q · filed 2021-11-10 | -$323.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$25.00K 10-Q · filed 2021-08-04 | $498.00K derived: sum of 3 quarters · filed 2021-08-04 | |
| 2020-03-31 | $148.00K 10-Q · filed 2021-05-11 | $671.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.71M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $1.19M 10-Q · filed 2020-12-10 |